December 19, 2022
The Ministry of Health, Labor and Welfare (MHLW) on December 16 granted orphan drug designation for five APIs including Takeda Pharmaceutical’s maralixibat chloride. Maralixibat was designated for two rare liver disease indications - Alagille syndrome and progressive familial intrahepatic cholestasis...read more